James A. Tumlin, MD
Quick facts
Marketed products
- Renin-Angiotensin (RAAS) alone · Cardiovascular
RAAS inhibitors block the renin-angiotensin-aldosterone system to reduce blood pressure and protect organs from hypertension-related damage.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about James A. Tumlin, MD
What are James A. Tumlin, MD's marketed drugs?
Top marketed products include Renin-Angiotensin (RAAS) alone.
Related
- Renin-Angiotensin (RAAS) alone · Cardiovascular
- Sector hub: All tracked pharma companies